S'abonner

Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals - 08/12/20

Doi : 10.1016/j.jinf.2020.09.024 
Ronald A. Seaton a, b, , Cheryl L. Gibbons c, Lesley Cooper b, William Malcolm c, Rachel McKinney d, Stephanie Dundas e, David Griffith f, Danielle Jeffreys g, Kayleigh Hamilton h, Brian Choo-Kang i, Suzanne Brittain j, Debbie Guthrie k, Jacqueline Sneddon b
a Infection unit, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow G51 4TF, UK 
b Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow G1 2NP, UK 
c National ARHAI Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, UK 
d Regional Infectious diseases unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK 
e Infection unit, University Hospital Monklands, Monkscourt Avenue, Airdrie ML6 OJS, UK 
f Department of Microbiology, Victoria Infirmary, Hayfield Road, Kirkcaldy KY2 5AH, UK 
g Department of Medical Education, Centre For Health Science, Old Perth Road, Inverness IV2 3UJ 
h Antimicrobial Management Team, University Hospital Crosshouse, Kilmarnock Road, Crosshouse, Kilmarnock KA2 0BE, UK 
i Respiratory Medicine unit, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF, UK 
j Antimicrobial Management Team, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill road, Aberdeen AB25 2ZN, UK 
k Pharmacy Department, Ninewells Hospital, James Arrott Drive, Dundee DD2 1SG, UK 

Corresponding author at: Infection unit, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow G51 4TF, UK.Infection unitQueen Elizabeth University Hospital1345 Govan RoadGlasgowG51 4TFUK

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

Antibiotic prevalence survey of 2/5 hospitalised SARS-CoV-2 patients at the epidemic peak in Scotland.
Antibiotics in 38% SARS-CoV-2 patients in wards and critical care units.
Narrow spectrum antibiotics predominant in wards reflecting national recommendations.
Broad spectrum antibiotics and antifungals in critical care indicative of suspected nosocomial bacterial and fungal infections.
Lower odds of antibiotic associated with nosocomial COVID-19, diabetes and in elderly care.

Le texte complet de cet article est disponible en PDF.

Summary

Background

Concern regarding bacterial co-infection complicating SARS-CoV-2 has created a challenge for antimicrobial stewardship. Following introduction of national antibiotic recommendations for suspected bacterial respiratory tract infection complicating COVID-19, a point prevalence survey of prescribing was conducted across acute hospitals in Scotland.

Methods

Patients in designated COVID-19 units were included and demographic, clinical and antimicrobial data were collected from 15 hospitals on a single day between 20th and 30th April 2020. Comparisons were made between SARS-CoV-2 positive and negative patients and patients on non-critical care and critical care units. Factors associated with antibiotic prescribing in SARS-CoV-2 positive patients were examined using Univariable and multivariable regression analyses.

Findings

There were 820 patients were included, 64.8% were SARS-CoV-2 positive and 14.9% were managed in critical care, and 22.1% of SARS-CoV-2 infections were considered probable or definite nosocomial infections. On the survey day, antibiotic prevalence was 45.0% and 73.9% were prescribed for suspected respiratory tract infection. Amoxicillin, doxycycline and co-amoxiclav accounted for over half of all antibiotics in non-critical care wards and meropenem, piperacillin-tazobactam and co-amoxiclav accounted for approximately half prescribed in critical care. Of all SARS-CoV-2 patients, 38.3% were prescribed antibiotics. In a multivariable logistic regression analysis, COPD/chronic lung disease and CRP ≥ 100 mg/l were associated with higher odds and probable or confirmed nosocomial COVID-19, diabetes and management on an elderly care ward had lower odds of an antibiotic prescription. Systemic antifungals were prescribed in 9.8% of critical care patients and commenced a median of 18 days after critical care admission.

Interpretation

A relatively low prevalence of antibiotic prescribing in SARS-CoV-2 hospitalised patients and low proportion of broad spectrum antibiotics in non-critical care settings was observed potentially reflecting national antimicrobial stewardship initiatives. Broad spectrum antibiotic and antifungal prescribing in critical care units was observed indicating the importance of infection prevention and control and stewardship initiatives in this setting.

Funding

The Scottish Antibiotic Prescribing Group is funded by Scottish Government.

Le texte complet de cet article est disponible en PDF.

Keywords : SARS-CoV-2, Antimicrobial stewardship, Antibiotic stewardship, Scottish antimicrobial prescribing group, Nosocomial infection, Bacterial co-infection, Coronavirus, Nosocomial fungal infection


Plan


Crown Copyright © 2020  Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 81 - N° 6

P. 952-960 - décembre 2020 Retour au numéro
Article précédent Article précédent
  • The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19
  • Harun Kundi, Elif Hande Özcan Çetin, U?ur Canpolat, Sevgi Aras, Osman Celik, Naim Ata, Suayip Birinci, Serkan Çay, Özcan Özeke, Ibrahim Halil Tanbo?a, Serkan Topalo?lu
| Article suivant Article suivant
  • Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study
  • Ar K Aung, Tess Aitken, Bing M Teh, Christiaan Yu, Richard Ofori-Asenso, Ken L Chin, Danny Liew

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.